Eupraxia Pharmaceuticals Inc.
Pharmaceutical company · Vancouver, British Columbia, Canada · Nasdaq: EPRX
Eupraxia Pharmaceuticals Inc. is a pharmaceutical company headquartered in Vancouver, British Columbia, Canada. Its earliest recorded incorporation is in 2012. Its shares trade on Nasdaq under the ticker EPRX. It has reported private securities offerings to the US SEC, most recently $1.9 million sold in a notice filed in 2024.
Eupraxia Pharmaceuticals at a glance
What does Eupraxia Pharmaceuticals do?
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $1.9 million sold (2024).
Frequently asked questions about Eupraxia Pharmaceuticals
Where is Eupraxia Pharmaceuticals headquartered?
Eupraxia Pharmaceuticals Inc. is headquartered in Vancouver, British Columbia, Canada.
What does Eupraxia Pharmaceuticals do?
Eupraxia Pharmaceuticals Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Eupraxia Pharmaceuticals a public company?
Yes. Eupraxia Pharmaceuticals Inc. trades on Nasdaq under the ticker EPRX.
When was Eupraxia Pharmaceuticals founded?
The earliest incorporation on record for Eupraxia Pharmaceuticals Inc. is in 2012, according to public company registers.
Similar companies
- AbCellera Biologics Inc.Vancouver, British Columbia, Canada
- InMed Pharmaceuticals Inc.Vancouver, British Columbia, Canada
- Clearmind Medicine Inc.Vancouver, British Columbia, Canada
- Aurinia Pharmaceuticals Inc.Edmonton, Alberta, Canada
- Medicenna Therapeutics Corp.Toronto, Ontario, Canada
- Satellos Bioscience Inc.Markham, Ontario, Canada
- Edesa Biotech, Inc.Markham, Ontario, Canada
- Lexaria Bioscience Corp.Kelowna, British Columbia, Canada
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.